Triple
T16851833
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Velpatasvir |
E409693
|
entity |
| Predicate | targets |
P860
|
FINISHED |
| Object |
HCV NS5A protein
HCV NS5A protein is a multifunctional nonstructural hepatitis C virus protein essential for viral RNA replication and assembly, and a key target of several direct-acting antiviral drugs.
|
E1236232
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: HCV NS5A protein | Statement: [Velpatasvir, targets, HCV NS5A protein]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: HCV NS5A protein Context triple: [Velpatasvir, targets, HCV NS5A protein]
-
A.
hepatitis C virus
Hepatitis C virus is a bloodborne RNA virus that primarily infects the liver, often causing chronic hepatitis, cirrhosis, and an increased risk of liver cancer.
-
B.
Harvoni
Harvoni is a prescription antiviral medication used to treat chronic hepatitis C virus (HCV) infection.
-
C.
Epclusa
Epclusa is a prescription antiviral medication used to treat chronic hepatitis C infection across all major genotypes.
-
D.
Sovaldi
Sovaldi is a breakthrough antiviral medication used to treat chronic hepatitis C by directly inhibiting the virus’s replication.
-
E.
Nadvirna
Nadvirna is a town in western Ukraine known as a local administrative and industrial center in the Ivano-Frankivsk region.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: HCV NS5A protein Triple: [Velpatasvir, targets, HCV NS5A protein]
Generated description
HCV NS5A protein is a multifunctional nonstructural hepatitis C virus protein essential for viral RNA replication and assembly, and a key target of several direct-acting antiviral drugs.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: HCV NS5A protein Target entity description: HCV NS5A protein is a multifunctional nonstructural hepatitis C virus protein essential for viral RNA replication and assembly, and a key target of several direct-acting antiviral drugs.
-
A.
hepatitis C virus
Hepatitis C virus is a bloodborne RNA virus that primarily infects the liver, often causing chronic hepatitis, cirrhosis, and an increased risk of liver cancer.
-
B.
Harvoni
Harvoni is a prescription antiviral medication used to treat chronic hepatitis C virus (HCV) infection.
-
C.
Epclusa
Epclusa is a prescription antiviral medication used to treat chronic hepatitis C infection across all major genotypes.
-
D.
Sovaldi
Sovaldi is a breakthrough antiviral medication used to treat chronic hepatitis C by directly inhibiting the virus’s replication.
-
E.
Nadvirna
Nadvirna is a town in western Ukraine known as a local administrative and industrial center in the Ivano-Frankivsk region.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d88395e6c88190b22730f335107c14 |
completed | April 10, 2026, 4:59 a.m. |
| NER | Named-entity recognition | batch_69e3b379b8fc81908d8bc9950c7f8bad |
completed | April 18, 2026, 4:38 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_6a00bb216fac81909d401c6b9911d1e0 |
completed | May 10, 2026, 5:06 p.m. |
| NEDg | Description generation | batch_6a00bb9b2b1881908f9f5c3dd1a2d500 |
completed | May 10, 2026, 5:08 p.m. |
| NED2 | Entity disambiguation (via description) | batch_6a00bc3a4b888190bd190b9330e2777d |
completed | May 10, 2026, 5:11 p.m. |
Created at: April 10, 2026, 5:24 a.m.